Earnings Call · Q1 FY2025·2025-05-13

Q1 25EPS -65.63%·Rev n/aQ4 24EPS +48.39%·Rev n/aQ3 24EPS -11.76%·Rev n/aQ2 24EPS -6.06%·Rev n/a⚠ consensus missing

CAPRICOR THERAPEUTICS, INC. CAPR

A.J. Bergmann — Chief Financial Officer

Linda Marban — Chief Executive Officer

+2.7%1d on move date+2.0% vs SPY3d+34.5%5d+45.9%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CAPR calls or request research access.

More CAPR calls Browse calls Request research access